Prosecution Insights
Last updated: November 16, 2026
Application No. 18/916,512

SYSTEMS AND METHODS FOR CONCURRENTLY DELIVERING HIGH FREQUENCY AND LONG PULSE WIDTH ELECTRICAL STIMULATION

Non-Final OA §102
Filed
Oct 15, 2024
Priority
Apr 25, 2022 — provisional 63/334,270 +1 more
Examiner
ROANE, AARON F
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Nevro Corp.
OA Round
1 (Non-Final)
73%
Grant Probability
Favorable
1-2
OA Rounds
83%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
661 granted / 900 resolved
+3.4% vs TC avg
Moderate +10% lift
Without
With
+9.8%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
44 currently pending
Career history
946
Total Applications
across all art units

Office Action

§102
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-3, 9-10, 12-17, 21, 23-24, and 26-31 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Waldhauser et al. (U.S. Patent 2021/0370055). Regarding claims 1, and 15, Waldhauser et al. disclose a method comprising: programming a signal generator (“programmable pulse generator 2115,” [0903]) to: deliver a first electrical signal to a target neural population of the patient via a first set of electrodes (electrical pulse/signal delivered through the electrodes 2222 on a first spline of splines 2210, see [0928] and figure 22E) of an implanted signal delivery device, the first electrical signal having individual pulses having a pulse width within a pulse width range of from about 5 milliseconds to about 2 seconds (see [0890]); and deliver a second electrical signal to the target neural population via a second set of electrodes (electrical pulse/signal delivered through the electrodes 2222 on a second spline of splines 2210 different from the first spline, see [0928] and figure 22E) of the implanted signal delivery device, the second electrical signal having a frequency within a frequency range of from about 1.2 kHz to about 100 kHz (see [0890]), wherein the first set of electrodes is different than the second set of electrodes, and wherein delivery of the first electrical signal at least partially temporally overlaps with delivery of the second electrical signal (see [0094], and [0890] for example). Regarding claims 2-3, and 16-17, Waldhauser et al. disclose the claimed invention, see [0890]. Regarding claims 9-10, and 23-24, Waldhauser et al. disclose the claimed invention, see figure 22E. Regarding claims 12-14, and 26-28, Waldhauser et al. disclose the claimed invention since heart/cardiac tissue and nerves which are peripheral also see [0241] and/or [0672] for the vagal/vagus nerve. Regarding claim 21, Waldhauser et al. disclose the claimed invention, see [0241]. Regarding claim 29, Waldhauser et al. disclose the system comprising: a signal delivery device having a plurality of electrodes (electrodes 2222 on the splines 2210, see [0928] and figure 22E) and configured to be implanted proximate a target neural population of a patient; and a signal generator (“programmable pulse generator 2115,” [0903]) having a computer readable storage medium with instructions that, when executed, cause the signal generator to: deliver a first electrical signal to a target neural population of the patient via a first set of electrodes (electrical pulse/signal delivered through the electrodes 2222 on a first spline of splines 2210, see [0928] and figure 22E) of an implanted signal delivery device, the first electrical signal having individual pulses having a pulse width within a pulse width range of from about 5 milliseconds to about 2 seconds (see [0890]); and deliver a second electrical signal to the target neural population via a second set of electrodes (electrical pulse/signal delivered through the electrodes 2222 on a second spline of splines 2210 different from the first spline, see [0928] and figure 22E) of the implanted signal delivery device, the second electrical signal having a frequency within a frequency range of from about 1.2 kHz to about 100 kHz (see [0890]), wherein the first set of electrodes is different than the second set of electrodes, and wherein delivery of the first electrical signal at least partially temporally overlaps with delivery of the second electrical signal (see [0094], and [0890] for example). Regarding claims 30-31, Waldhauser et al. disclose the claimed invention, see figure 22E. Allowable Subject Matter Claims 4-8, 11, 18-20, 22, and 25 objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to AARON F ROANE whose telephone number is (571)272-4771. The examiner can normally be reached generally Mon-Fri 8am-9pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Niketa Patel can be reached at (571) 272-4156. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AARON F ROANE/Primary Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Oct 15, 2024
Application Filed
Sep 02, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12788389
BIOLOGICAL FLUID DRAINAGE DEVICES, SYSTEMS, AND METHODS
3y 10m to grant Granted Nov 10, 2026
Patent 12779245
SYSTEMS, METHODS, AND APPARATUS FOR OCULAR LASER THERAPY
3y 10m to grant Granted Nov 03, 2026
Patent 12758334
METHODS AND APPARATUS FOR SURGICAL TABLE STABILIZATION
2y 3m to grant Granted Oct 13, 2026
Patent 12758105
EAR SYSTEM
2y 1m to grant Granted Oct 13, 2026
Patent 12758359
ANALGESIC DEVICE
1y 0m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
73%
Grant Probability
83%
With Interview (+9.8%)
Low
PTA Risk
Based on 900 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month